BRIEF-Basilea Pharmaceutica submits Isavuconazole European marketing authorization application

July 17 Thu Jul 17, 2014 1:27am EDT

Related Topics

July 17 (Reuters) - Basilea Pharmaceutica AG : * Submits Isavuconazole European marketing authorization application for the

treatment of invasive mold infections * Source text for Eikon * Further company coverage

FILED UNDER: